Patient presents with symptoms suggestive of vaping-related lung injury, also known as EVALI, or vaping-associated pulmonary illness.  Chief complaints include cough, shortness of breath, and chest pain, potentially indicating vaping-related respiratory distress or bronchiolitis.  Onset of symptoms began approximately [Number] daysweeksmonths ago, correlating with the patient's reported history of e-cigarette use, specifically vaping [Substance, e.g., nicotine, THC, CBD].  Patient reports vaping [Frequency] with a [Device type, e.g., vape pen, mod, pod system]. Physical examination reveals [Findings, e.g., tachypnea, rales, wheezing].  Differential diagnosis includes pneumonia, bronchitis, and other respiratory infections.  Preliminary assessment suggests a diagnosis of vaping-related disorder, specifically [ICD-10 code: J68.X], with suspected chemical pneumonitis as a contributing factor.  Treatment plan includes oxygen therapy as needed, cessation of vaping, monitoring of respiratory function, and supportive care.  Patient education provided regarding the risks of vaping and the importance of smoking cessation. Follow-up scheduled in [Timeframe] to assess respiratory status and adjust treatment as necessary. Further investigation may include chest X-ray, CT scan, and arterial blood gas analysis to rule out other respiratory conditions and monitor disease progression.  Prognosis dependent on patient compliance with treatment and cessation of vaping.  Potential long-term complications discussed, including chronic obstructive pulmonary disease (COPD) and interstitial lung disease.